STOCK TITAN

Major Innovex International (INVX) holder trims via 5.75M-share secondary sale

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Innovex International’s major shareholder group updated its ownership after a large secondary stock sale. Selling stockholders agreed to sell 5,750,000 shares of common stock at $25.75 per share, and the underwriters fully exercised a 30-day option for another 862,500 shares.

The selling stockholders received $24.59125 per share, reflecting underwriting discounts. As part of the same transaction, Innovex repurchased 575,000 of these shares under its existing buyback program. After these moves, Amberjack-related entities and affiliates may be deemed to beneficially own 22,757,322 shares, or 33.2% of the 68,563,690 shares outstanding as of February 27, 2026.

Positive

  • None.

Negative

  • None.

Insights

Large secondary sale by existing funds, with Innovex simultaneously repurchasing shares, leaves Amberjack-affiliated group at a sizeable 33.2% stake.

The disclosure describes a secondary offering of 5,750,000 Innovex shares by existing investment funds at $25.75 per share, plus a fully exercised 862,500-share underwriters’ option. These are existing shares, so the sale primarily shifts ownership from the selling funds to public investors rather than creating new dilution.

Innovex also bought back 575,000 shares through its existing share repurchase program, slightly reducing the public float versus what it would otherwise have been. Post-transaction, Amberjack Capital Partners and related entities may be deemed to beneficially own 22,757,322 shares, or 33.2% of the 68,563,690 shares outstanding as of February 27, 2026, indicating continued concentrated ownership.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Amberjack Capital Fund II, L.P.
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner of Amberjack Capital Associates II, LLC, the general partner of Amberjack Capital GP II, L.P., its general partner
Date:02/27/2026
Innovex Co-Invest Fund II, L.P.
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner of Innovex Co-Invest Associates, LLC, the general partner of Innovex Co-Invest Fund II GP, L.P., its general partner
Date:02/27/2026
Innovex Co-Invest Fund, L.P.
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner of Innovex Co-Invest Associates, LLC, the general partner of Innovex Co-Invest Fund GP, L.P., its general partner
Date:02/27/2026
Intervale Capital Fund II, L.P.
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner of Intervale Capital Associates II, LLC, the general partner of Intervale Capital GP II, L.P., its general partner
Date:02/27/2026
Intervale Capital Fund II-A, L.P.
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner of Intervale Capital Associates II, LLC, the general partner of Intervale Capital GP II, L.P., its general partner
Date:02/27/2026
Intervale Capital Fund III, L.P.
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner of Intervale Capital Associates III, LLC, the general partner of Intervale Capital GP III, L.P., its general partner
Date:02/27/2026
Amberjack Capital GP II, L.P.
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner of Intervale Capital Associates II, LLC, its general partner
Date:02/27/2026
Innovex Co-Invest Fund II GP, L.P.
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner of Innovex Co-Invest Associates, LLC, its general partner
Date:02/27/2026
Innovex Co-Invest Fund GP, L.P.
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner of Innovex Co-Invest Associates, LLC, its general partner
Date:02/27/2026
Intervale Capital GP II, L.P.
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner of Intervale Capital Associates II, LLC, its general partner
Date:02/27/2026
Intervale Capital GP III, L.P.
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner of Intervale Capital Associates III, LLC, its general partner
Date:02/27/2026
Amberjack Capital Associates II, LLC
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner
Date:02/27/2026
Innovex Co-Invest Associates, LLC
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner
Date:02/27/2026
Interval Capital Associates II, LLC
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner
Date:02/27/2026
Intervale Capital Associates III, LLC
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner
Date:02/27/2026
Amberjack Capital Partners, L.P.
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner of Amberjack Management, LLC, its general partner
Date:02/27/2026
Amberjack Management, LLC
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky / Partner
Date:02/27/2026
Turowsky Jason
Signature:/s/ Jason Turowsky
Name/Title:Jason Turowsky /Self
Date:02/27/2026

FAQ

How many Innovex (INVX) shares were sold in the secondary offering?

Existing Innovex shareholders sold 5,750,000 shares of common stock in the offering. In addition, underwriters fully exercised an option to purchase 862,500 extra shares, increasing the total number of shares sold by the selling stockholders into the market.

At what price were Innovex (INVX) shares sold and what did sellers receive?

Shares were offered to the public at $25.75 each. The selling stockholders received $24.59125 per share, reflecting underwriting discounts. This per-share amount is specifically disclosed as the net price received by the selling funds for the stock they sold.

Did Innovex (INVX) repurchase any shares in connection with this transaction?

Yes. Innovex agreed to repurchase 575,000 shares of common stock from the underwriters. The repurchase was made under the company’s existing share repurchase program and involved shares that were part of the same secondary offering structure.

What is Amberjack’s group ownership stake in Innovex (INVX) after the sale?

Amberjack Capital Partners and related entities may be deemed to beneficially own 22,757,322 Innovex shares. This represents 33.2% of the company’s 68,563,690 shares of common stock outstanding as of February 27, 2026, indicating a significant continuing ownership position.

How many Innovex (INVX) shares are outstanding after these transactions?

The filing states that 68,563,690 shares of Innovex common stock were outstanding as of February 27, 2026. This figure, drawn from the company’s prospectus supplement, is used to calculate the percentage ownership of the reporting Amberjack-related entities.

What lock-up restrictions apply to the Innovex (INVX) selling stockholders?

Selling stockholders entered a lock-up agreement running for 45 days after the date of the final prospectus. During this period, they agreed not to transfer Innovex common stock or related shares without underwriter consent, subject to specified exceptions detailed in the lock-up agreement.

Who were the underwriters for the Innovex (INVX) secondary offering?

J.P. Morgan Securities LLC acted as representative of the several underwriters. The underwriting agreement among Innovex, the selling stockholders, and these underwriters governed the 5,750,000-share offering and the fully exercised 862,500-share option described in the ownership amendment.
Innovex International Inc

NYSE:INVX

INVX Rankings

INVX Latest News

INVX Latest SEC Filings

INVX Stock Data

1.84B
38.00M
Oil & Gas Equipment & Services
Oil & Gas Field Machinery & Equipment
Link
United States
HUMBLE